# A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

> **NCT03244800** · PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 65 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** MEDI0382
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03244800
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-04
- **Primary completion:** 2018-01-23
- **Final completion:** 2018-01-23
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03244800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03244800, "A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03244800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*